QA: Allergan INC in us_pharma/2010

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000850693_2011_Allergan_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000850693, Allergan INC

  xvar xval
0 AssetsCurrent 3,993,700,000
1 IntangibleAssetsNetIncludingGoodwill 3,034,600,000
2 PropertyPlantAndEquipmentNet 800,600,000
3 remainder_Assets 479,200,000
4 LiabilitiesCurrent 1,528,400,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,017,600,000
9 ResearchAndDevelopmentExpense 804,600,000
10 remainder_Expenses 2,004,500,000
11 remainder_Revenues 4,919,400,000
12 remainder_NetIncome -87,800,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,308,100,000
1 Liabilities 1,528,400,000
2 Expenses 4,826,700,000
3 Revenues 4,919,400,000
4 StockholdersEquity 6,779,700,000
5 NetIncome 4,900,000
6 ComprehensiveNetIncome 4,900,000
7 BaseVar 9,835,200,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.01
9 EconomicCapitalRatio 3.69

Edgar->Model Mapping

Feature Distribution

Change over Time